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CONE BEAM COMPUTER TOMOGRAPHY (CBCT) VERIFICATION OF 
STEREOTACTIC BODY RADIOTHERAPY (SBRT): A PROSPECTIVE 
ANALYSIS ON THE CONCORDANCE BETWEEN RADIATION 
THERAPISTS AND RADIATION ONCOLOGISTS 
Rosanna Yeung, James Sidney, Robynn Ferris, Jenny Soo, 
Mitchell Liu 
British Columbia Cancer Agency, Vancouver, BC 
 
Purpose: Image-guidance to ensure correct patient set-up prior 
to treatment delivery is of utmost importance in SBRT. Many 
studies have demonstrated high levels of concordance between 
radiation therapists (RTs) and radiation oncologists (ROs) on daily 
verification based on electronic portal imaging and simulator 
films. There is limited data, however, on the concordance 
between RTs and ROs using CBCT pre-treatment images prior to 
SBRT. The primary objective of this study is to evaluate the level 
of concordance between RTs and ROs on CBCT pre-treatment 
verification images for SBRT. 
Methods and Materials: Twenty-one consecutively treated SBRT 
patients at a provincial institution were included in the study. 
CBCT was performed by both RO and RTs prior to delivery of each 
fraction for abdominal and bone SBRT treatments, and prior to 
first fraction for lung SBRT. RTs performed subsequent daily 
matches for lung SBRT. Initial CBCT match was performed by RTs 
as per centre guidelines or by previously specified instructions. 
ROs performed second match prior to SBRT delivery. Directional 
differences between RT and RO match were recorded and 
analyzed. Intraclass correlation coefficients were calculated to 
determine variability between RT and RO match, with values 
approaching 1 suggesting high concordance. 
Results: Thirty-six CBCT images were analyzed. Thirteen were 
lung, 20 abdominal (five liver, 15 pancreas) and three were bone 
SBRT cases. RO made adjustments to initial RT match in 12 (33%) 
of CBCT matches, with six matches having a direction shift of 0.1 
to < 0.2 cm in any direction, and two matches with a directional 
shift of ≥ 0.2 cm. Mean maximum match difference was 0.12 cm 
(range: 0.02, 0.31 cm). Treatments requiring adjustment to the 
initial RT match did not differ by treatment site. Review of the 
two plans with match difference of ≥ 0.2 cm revealed no 
appreciable change in GTV coverage and with dose to organs at 
risk still within accepted constraints. Intraclass correlation 
coefficients for all CBCT matches were 0.998 (95% CI: 0.996-
0.999), 0.997 (95% CI: 0.995-0.999), 0.996 (95% CI: 0.992-0.998) 
in the x, y, and z directions respectively. Intraclass correlation 
coefficients for CBCT matches that required adjustment by RO 
were similar at 0.995 (95%CI: 0.982-0.9980.982-0.998), 0.995 
(95% CI: 0.984-0.9990.984-0.999), 0.989 (95% CI: 0.962-0.997) in 
the x, y, and z directions respectively.  
Conclusions: CBCT match for SBRT at our center shows high 
concordance between RTs and ROs. These findings support 
potential expansion of RT scope of practice at our institution to 
include independent CBCT matches for SBRT. 
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CONE BEAM VERSUS STICK METHOD: A RETROSPECTIVE ANALYSIS 
COMPARING THE ACCURACY OF CONE BEAM GAP MEASUREMENTS 
TO CONVENTIONAL STICK MEASUREMENTS FOR HEAD AND NECK 
PATIENTS UNDERGOING RADIATION THERAPY  
Josslynn Spence1, Steven Brown1, Robert Olson2 
1British Columbia Cancer Agency, Prince George, BC 
2University of British Columbia, Prince George, BC 
 
Purpose: Over the course of radiation therapy treatments for 
head and neck (H&N) cancers, many patients’ contours change 
shape due to weight loss. This affects the fit of the shell, and the 
shape of the planned dosimetric volumes. There are a variety of 
methods used to measure the change in a patients’ external 
contour over the course of their treatment. Investigation is 
needed to determine the effectiveness of these methods. The 
objective was to complete a retrospective analysis that 
compares the weekly use of Cone Beam Computed Tomography 
(CBCT) to a conventional method involving small wooden sticks. 
These methods assess the change in contour based on the 
distance of the skin to the immobilization shell. 
Methods and Materials: Measurements from eighteen H&N 
patients undergoing radiation therapy were used for this study. 
Strategic measurement points in areas with a high likelihood of 
contour variance due to weight loss or change in volume were 
provided from Dosimetry for each patient. Measurements were 
taken at gantry angles of 0, 90, and 270 once per week using both 
CBCT and conventional stick measurement techniques for the 
duration of treatment. A comparison of gap measurements 
between stick and CBCT methods was performed with a paired t-
test. 
Results: Irrespective of gap measurement method, mean gap 
measurements were significantly smaller at 0 (1.41 mm), 
compared to 90 (2.95 mm) and 270 (2.52 mm) degrees (p < 
0.001). Mean gap measurements for week 1, 2, 3, 4, 5, 6, and 7 
were 1.5, 2.0, 2.3, 3.3, 4.0, 3.1, and 3.0, respectively (p < 
0.001). Including all time points and measurement angles, mean 
stick measurements were slightly larger than CBCT (2.5 versus 
2.2 mm; p = 0.02), though these differences were significantly 
larger when restricting to lateral measurements (3.1 versus 2.6 
mm; p = 0.002), or restricted to lateral measurements in last 
three weeks of RT (4.0 versus 2.5 mm; p < 0.001). 
Conclusions: Overall, conventional stick method overestimates 
the gap measurements compared to CBCT method. As treatment 
progresses, the gap measurements increase as well as the 
differential between the two methods. Future studies including 
a larger sample size of patients that extend past the four week 
mark of treatment could determine if the overestimation of stick 
gap measurements results in more patients being re-planned 
compared to CBCT. 
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ELECTROMAGNETIC TRACKING FOR CATHETER INSERTION 
GUIDANCE FOR HDR BREAST BRACHYTHERAPY: DEMONSTRATION 
OF CONCEPT IN PHANTOMS  
Harry C. Brastianos, Thomas Vaughan, Andras Lasso, Mary 
Westerland, James Gooding, Gabor Fichtinger, Conrad Falkson 
Queen's University, Kingston, ON 
 
Purpose: In Canada, in 2015 an estimated 25,000 women were 
diagnosed with breast cancer. For early-breast stage cancer, the 
recommended treatment is breast conserving surgery followed 
by radiation therapy. The standard of care is whole-breast 
irradiation, which requires a treatment time of four to six weeks. 
Accelerated partial breast irradiation by multi-catheter 
interstitial brachytherapy is an alternative that is delivered in 
just one week or less. To achieve ideal dosimetry over the 
tumour bed, the catheters must be placed parallel with equal 
spacing in the deformable breast tissue - a technical challenge 
that requires image guidance. Ultrasound (US) imaging is a safe 
and affordable guidance modality, but it is difficult to use in the 
presence of interference between the catheters. We propose 
using real-time electromagnetic (EMT) navigation to shore up the 
US-guided catheter insertion process. 
Methods and Materials: A tissue-locking needle and US probe are 
equipped with EMT. Under US guidance, the needle is inserted 
and locked in the tumour bed, providing a locally rigid reference. 
The target volume is segmented in US, yielding a tracked model 
in a virtual view. An EMT-enabled needle guide is pointed at the 
target and a catheter needle is inserted through the guide into 
the tissue. Additional parallel catheters are planned on the 
virtual view based on the first insertion and implanted in the 
target. The guidance software is built on the 3D Slicer 
(www.slicer.org) open source platform. 
Anthropomorphic plastic phantoms were created, each 
containing a simulated tumour bed that can be visualized in both 
US and CT. In our experiment, two rows of five catheter needles 
per row, for a total of 10 catheters were inserted in two 
phantoms. The intention was to place each catheter 1 cm apart. 
The first phantom had catheter needles inserted under sole US 
guidance to the target and the second under combined EMT-US 
guidance. Both insertions were performed by the same operator. 
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The position of the catheters relative to the tumour bed was 
measured in CT. 
Results: With sole US guidance, seven out of 10 catheters passed 
through the tumour bed. The catheter spacing was inconsistent 
and the desired goal of two rows of five equally-spaced catheters 
was not precisely achieved, with a mean spacing of 1.0 cm with 
0.7 - 1.9 cm range. Under combined EMT-US guidance, nine out 
of 10 catheters passed through the tumour bed, yielding two 
rows of five catheters with more consistent spacing, with a mean 
spacing of 1.0 cm with 0.8-1.2 cm range. 
Conclusions: This phantom experiment suggests that combined 
EMT-US guidance can help achieve consistent catheter spacing 
over the tumour bed. These results are preliminary, and a trial 
of the method is now being conducted to validate our results. 
Additional research is being conducted to translate the proposed 
navigation technique to patient trials. 
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BRACHYTHERAPY FOR ENDOBRONCHIAL METASTASIS: AN 
EFFECTIVE METHOD OF ACHIEVING PALLIATIVE RELIEF OF COUGH, 
HEMOPTYSIS, CHEST PAIN AND DYSPNEA  
Elysia Donovan1, Emilia Timotin1, Tom Farrell1, Bernard Donde2, 
Serge Puksa1, Ranjan Sur1 
1McMaster University, Hamilton, ON 
2Witwatersrand University, Johannesburg, South Africa
Purpose: Endobronchial metastasis originating from primary 
cancers outside the lung are rare in comparison with 
parenchymal metastasis. External beam radiotherapy (EBRT) is 
often attempted for control of cough, hemoptysis, chest pain and 
dyspnea with variable effectiveness and potential toxicities. 
There are also limitations to re-treatment with EBRT if symptoms 
recur. Documented experience in the use of brachytherapy for 
these patients is very limited in the literature. We report a 
cohort of patients with endobronchial metastasis treated with 
high-dose rate (HDR) brachytherapy at our center. 
Methods and Materials: A prospective database was created 
from 2006-2015 including demographic, treatment and outcome 
data. Patients with endobronchial metastasis from any primary 
site outside the lung who received one or more high-dose rate 
brachytherapy treatments with iridium-192 were included. 
Cough, dyspnea, chest pain and hemoptysis were assessed and 
graded by the primary medical team as absent (0), mild (1), 
moderate (2), significant (3), and severe (4) at the time of initial 
consult and in follow up. The duration of symptom improvement 
and re-expansion of the lung documented on imaging were 
analyzed using Kaplan-Meier curves.  
Results: Thirty-five patients with endobronchial metastasis were 
identified (14 GIT, five breast, three each of 
sarcoma, lymphoma, melanoma, renal cell, two head and 
neck, one cervix and one testicle). The majority of patients 
received three fractions of 700 cGy, and 15 patients had 
received EBRT to the lung beforehand and four afterwards. 
Median symptom-free survival was 67 days and overall 
survival was 117 days. Of patients reporting the presence 
of symptoms at baseline, improvement in cough was 
documented in 75.0 % (21/28), hemoptysis in 76.4% (13/18), 
pain in 64.3% (9/14) and dyspnea in 60.0% (18/30) for a median 
of three, three, three and six months respectively. Absent to 
mild cough (n = 8), hemoptysis (n = 17), pain (n = 21), and 
dyspnea (n = 6) scores were maintained for median periods of 
two, three and four months respectively. Of the 22 patients 
who had subsequent chest imaging, re-expansion was 
documented in 32%. There were no significant toxicities 
reported. 
Conclusions: Brachytherapy appears effective in achieving 
durable symptom control of cough hemoptysis and dyspnea in 
patients with metastatic disease located in the bronchus. It can 
be used in combination with or as an alternative to external 
beam radiotherapy, and should be considered routinely where 
available in this patient population. Further studies are required 
to better characterize expected symptom improvement and lung 
re-expansion rates. 
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HIGH-DOSE RATE BRACHYTHERAPY FOR THE MANAGEMENT OF 
MALIGNANT ENDOBRONCHIAL OBSTRUCTION AND HEMOPTYSIS: 
INSTITUTIONAL CASE SERIES OF 28 PATIENTS  
Martin Korzeniowski1, Christine D'Arsigny1, Onofre Moran-
Mendoza1, Mary Westerland2, Conrad Falkson1 
1Queen's University, Kingston, ON 
2Cancer Centre of Southeastern Ontario, Kingston, ON 
Purpose: Endobronchial complications of primary and metastatic 
lung malignancy contribute to considerable patient morbidity 
and adversely affect quality-of-life with symptoms of dyspnea 
and hemoptysis. Endobronchial High-Dose Rate (HDR) 
Brachytherapy is an efficacious treatment strategy indicated for 
large obstructing endobronchial lesions not amenable for surgical 
resection, combination treatment with external beam 
radiotherapy for potentially improved local control and for the 
palliation of symptoms in the re-treatment setting. The purpose 
of this study was to explore the clinical features and outcomes 
in a consecutive series of patients treated for malignant 
endobronchial obstruction at a single institution. 
Methods and Materials: A retrospective analysis was performed 
on all consecutive patients treated at the Cancer Centre of 
Southeastern Ontario with endobronchial HDR Brachytherapy 
between November 2012 and March 2015. The demographic and 
clinical characteristics were collected and overall survival and 
symptomatic progression-free survival are reported. 
Results: Twenty-eight consecutively treated patients (17 male 
and 11 female) were identified for review. The average age at 
the time of treatment was 69.12 years. The majority of patients 
had a histopathological diagnosis of lung cancer (n = 21 non-small 
cell lung cancer, n = 1 small cell lung cancer) while the 
remainder (n = 6) had metastatic disease from other primaries. 
Fifteen patients had metastatic disease at presentation and nine 
were treated with systemic therapy prior to brachytherapy. The 
major indication for treatment included dyspnea (n = 18) and 
hemoptysis (n = 10) with 12 patients identified to have complete 
bronchial occlusion by bronchoscopy. Two patients were treated 
in a critical care setting and discharged home with stabilization 
of symptoms. The median overall survival for the group was 17.58 
weeks while the median symptomatic progression-free survival 
was 9.82 weeks. 
Conclusions: Endobronchial HDR brachytherapy remains an 
efficacious treatment strategy for patients presenting with 
malignant bronchial occlusion causing dyspnea and/or 
hemoptysis. Our experience demonstrates that carefully-
selected patients can experience effective palliation of 
symptoms despite an overall poor prognosis for the group. While 
limited, our experience also demonstrates that some patients 
with massive-hemoptysis or respiratory failure may benefit from 
treatment in the hands of a skilled brachytherapy team. 
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DO RECTAL TUBES IMPROVE DOSIMETRY IN INTERSTITIAL 
BRACHYTHERAPY FOR GYNECOLOGICAL MALIGNANCIES?  
Pencilla Lang1, Ananth Ravi2, Matt Wronski2, Lucas Castro 
Mendez2, Eric Leung2 
1University of Toronto, Toronto, ON 
2Sunnybrook Health Sciences Centre, Toronto, ON 
Purpose: The dosimetry of trans-perineal interstitial 
brachytherapy (ISBT) treatment of gynecological malignancies 
can be significantly affected by the presence of rectal gas. This 
study evaluates the impact of using a rectal tube on dosimetric 
factors. 
Methods and Materials: Twenty-nine patients treated between 
August and December 2015 at our institution were included in a 
prospective registry trial. Data on the use of a rectal tube and 
dosimetric parameters were collected. Rectal volume, maximum 
dose to 2 cc of the rectum contour (D2cc) and the minimum dose 
to 90% of the high-risk clinical target volume (HR-CTV D90) was 
compared using a t-test for the rectal tube and no rectal tube 
cohorts. The rectal volume was measured from 1cm above and 
